Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technical analysis for shorts & longs -- Ignore unavailable to you. Want to Upgrade?

To: Johnny Canuck who wrote (32716)	6/10/2001 3:30:40 PM
From: Johnny Canuck	Read Replies (1) \| Respond to of 68455

4. BABY BOOMERS FUEL DRUG SPENDING GROWTH Americans are going to double the amount they spend on prescription drugs over the next five years, says a new report from Merck Medco, the leading provider of prescription drugs in the U.S. That growth will be driven by baby boomers -- mainly people from ages 40 to 55. Merck Medco, which operates as a fully owned subsidiary of Merck & Co. (MRK, $74, unch.), said drug spending increased 14% in 2000 and is expected to more than double by 2006. More than half of that increase will come as a result of baby boomers using drugs that treat central nervous system and cardiovascular disorders. People over the age of 65, by contrast, generally spend about the same amount per year (or very slow growth) on prescription drugs. This age group does, however, spend the most per person, approximately $1,400 a year. TODD’S TAKE: No surprises here. Over the past few years we’ve mentioned time and time again that big drug companies are going to benefit from the baby boomer generation, but it’s nice to have that good news confirmed. Drug companies are making more and better prescription drugs all the time. Baby boomers, meanwhile, are reaching the age level where they tend to ramp up their prescription drug spending. As a result, we’re expecting to see incredible industry growth over the next few years and beyond. The demographic trends look encouraging, and we’re set to realize some great and protracted gains from a number of our pharmaceutical holdings, including Merck and Pfizer (PFE, $44, up 1).

To: Johnny Canuck who wrote (32716)	6/10/2001 6:25:25 PM
From: Return to Sender	Read Replies (2) \| Respond to of 68455

I basically agree with everything in that article but the title. >PC BUYERS NO LONGER HAVE THE NEED FOR SPEED< If PC makers were able to bundle an upgraded modem then that product alone would drive sales much higher. The hardware and software upgrades are not nearly as evident or needed as high speed Internet access out of the box. Harry if you get a chance take a look at ACTM. It's on my watch list here for a dip below 15 where it may be a good buy for a rebound back to 20 when the SOX finds another bottom. What do you think? finance.yahoo.com Thanks, RtS